<DOC>
	<DOCNO>NCT01183104</DOCNO>
	<brief_summary>The purpose study compare efficacy safety sitagliptin glimepiride drug naïve elderly patient T2DM evaluate HbA1c change baseline 52 W efficacy incidence hypoglycemia randomization 52 W safety . The clinical hypothesis non-inferiority sitagliptin glimepiride efficacy judge HbA1c change baseline 52 W superiority sitagliptin glimepiride safety judge incidence hypoglycemia drug naïve elderly patient T2DM . In addition , comparison efficacy extend 104W .</brief_summary>
	<brief_title>START-J : SiTAgliptin eldeRly Trial Japan</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>1 . Patients type 2 diabetes OHA naive , aGI BG monotherapy ( wash 4 week prior randomization ) 2 . Signed informed consent obtain trialrelated activity 3 . Treatment diet exercise 12 week longer screen 4 . Age = &gt; 60 y.o . 5 . Male Female 6 . HbA1c 6.9 % = &lt; &lt; 8.9 % 1 . Active proliferative retinopathy maculopathy require treatment 2 . Liver dysfunction ( &gt; x2 upper normal limit ) , moderate severe renal dysfunction ( serum Cr &gt; 1.5mg/dL male , Cr &gt; 1.3mg/dL female , GFR &lt; 30 ) , severe cardiac disease ( NYHA III IV ) , malignancy uncontrolled hypertension ( treat untreated ) judge Investigator 3 . Mental incapacity ( include moderate severe dementia ) preclude adequate understanding and/or cooperation judge Investigator 4 . Recurrent hypoglycaemia hypoglycaemic unawareness judge investigator 5 . Previous history severe allergy pharmaceutical product 6 . Systemic glucocorticoid user potential user 7 . Suspected type 1 diabetes ( include SPIDDM ) positive antiGAD antibody 8 . Any condition investigator consider potential obstacle trial participation and/or data analysis</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Sitagliptin</keyword>
	<keyword>Glimepiride</keyword>
	<keyword>Elderly patient</keyword>
	<keyword>Japanese</keyword>
</DOC>